Minerva Surgical, Inc. (UTRS) Tops Q2 EPS by 14c

Minerva Surgical, Inc. (NASDAQ: UTRS) reported Q2 EPS of ($0.20), $0.14 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $13 million versus the consensus estimate of $13.47 million.

For earnings history and earnings-related data on Minerva Surgical, Inc. (UTRS) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Activist investors push Seer, Inc. to disclose go-private timeline
• Bit Digital (BTBT) Misses Q2 EPS by 27c